| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aspira Women's Health Inc. | Chief Financial Officer | Common Stock | 33,000 | $111,210 | $3.37 | 17 Nov 2023 | Direct |
| Aspira Women's Health Inc. | Chief Financial Officer | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 22,000 | $70,400 | $3.20 | 13 May 2024 | Direct |
| Akari Therapeutics Plc | CFO | American Depository Shares representing Ordinary Shares | 200 | $244 | $1.22 | 10 Jan 2025 | Direct |
| Akari Therapeutics Plc | CFO | American Depositary Shares representing Ordinary Shares | 200 | $224 | $1.12 | 20 Mar 2025 | Direct |
| Akari Therapeutics Plc | CFO | Stock Option (Right to Buy) | 200,000 | 20 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | 20 Mar 2025 | 2 | $0 | 4 | CFO | 24 Mar 2025, 17:00 |
| AKTX | Akari Therapeutics Plc | 10 Jan 2025 | 1 | +$244 | 4 | CFO | 13 Jan 2025, 08:05 |
| AKTX | Akari Therapeutics Plc | 16 Dec 2024 | 0 | $0 | 3 | CFO | 20 Dec 2024, 16:30 |
| AWH | Aspira Women's Health Inc. | 13 May 2024 | 1 | $0 | 4 | Chief Financial Officer | 14 May 2024, 19:54 |
| AWH | Aspira Women's Health Inc. | 03 May 2024 | 1 | +$21,334 | 4 | Chief Financial Officer | 14 Jun 2024, 17:17 |
| AWH | Aspira Women's Health Inc. | 14 Feb 2024 | 1 | $0 | 4 | Chief Financial Officer | 14 Feb 2024, 20:17 |
| awh | Aspira Women's Health Inc. | 17 Nov 2023 | 1 | $0 | 4 | Chief Financial Officer | 20 Nov 2023, 19:37 |
| AWH | Aspira Women's Health Inc. | 08 Sep 2023 | 1 | +$9,658 | 4 | Chief Financial Officer | 12 Sep 2023, 19:37 |
| AWH | Aspira Women's Health Inc. | 25 Jul 2023 | 1 | $0 | 4 | Chief Financial Officer | 26 Jul 2023, 16:39 |
| AWH | Aspira Women's Health Inc. | 24 Jul 2023 | 1 | +$3,001 | 4 | Chief Financial Officer | 24 Jul 2023, 18:53 |
| AWH | Aspira Women's Health Inc. | 15 Jun 2023 | 0 | $0 | 3 | Chief Financial Officer | 29 Jun 2023, 16:34 |